Prostate Cancer Progression and the Epigenome

Prostate cancer is driven by interrelated genetic 1,2 and epigenetic 3 alterations. Known genetic contributors to sporadic prostate cancer are the presence of germline genetic variants that ...

Known genetic contributors to sporadic prostate cancer are the presence of germline genetic variants that in-crease the risk of prostate cancer and of somatic mutations, rearrangements, or ...
Prostate Cancer Epigenome

Abstract Prostate cancer is a major health burden within the ever-increasingly aging US population. The molecular mechanisms involved in prostate cancer are diverse and heterogeneous. In this context, epigenetic changes, both global and gene specific, are now an emerging alternate mechanism in disease initiation and progression . The three major risk factors in prostate cancer : age, geographic ...
Role of lncRNAs in prostate cancer development and progression . Weiss M, Plass C, Gerhauser C Biol Chem, 395 (11):1275-1290, 01 Nov 2014 Cited by: 19 articles | PMID: 25153594 Review

Interplay of the 3D genome and epigenome in androgen
Here, we present a perspective on how the spatial architecture of the epigenome , including 3D chromatin structure and dynamics, orchestrates dysregulation of transcription factor networks that help to drive disease progression in androgen-driven prostate cancer .
Epigenetic Regulation in Prostate Cancer The regulation of gene expression is critical both to normal development and to disease. Epigenetic Regulation in Prostate Cancer The regulation of gene expression is critical both to normal development and to disease. A recent study provides insight into how increased androgen-recepto...

PDF Prostate cancer epigenetics from pathophysiology to ...
Each section is structured to encompass the full spectrum of prostate cancer progression , from localized to metastatic disease, castration-resistant prostate cancer (CRPC) and neuroendocrine ...
In addition to somatic genetic alterations, deviations in the epigenetic landscape of cancer cells and their tumor microenvironment (TME) are critical drivers of prostate cancer initiation and progression .

PDF Prostate Cancer Epigenetics
Alterations in the epigenetic cityscape of pros-tatecancercellscomparedwithnormalprostatetissueshaveacomplexinterplay withgenetic alterations to drive prostate cancer initiation and progression . Indeed, mutations in genes encoding epigenetic enzymes are often observed in human cancers including prostate cancer .







Prioritizing biomarker-oriented clinical trials is essential to identify specific molecular subgroups of patients with prostate cancer who are most likely to benefit from epigenetic drugs.